CD40 and myeloid sarcoma: We then returned to the clinical samples to assess the expression profile of SIRT1 and discovered that MS patient B cells exhibited significantly lesser induction of SIRT1 mRNA, compared with HS B cells, when activated with ‘dual BCR+CD40 stimulation’ (Figure 3A).